White Rose Health Innovation Partnership* (HIP) has been created and funded to accelerate the translation of promising health-related technologies, products, procedures and services toward clinical application. The partnership will:

• Use a unique combination of methods (not yet tried in the UK) including decision analysis and accelerated radical innovation methodologies

• Create an open innovation platform in which all stakeholders can collaborate in exploiting their intellectual property (IP) effectively

• Create learning resources for the innovation supply chain

• Enhance UK operations by drawing on the experience of mature medical technology markets in the US with focus on New Jersey

• Develop new opportunities by working with emerging markets in China

New Jersey's participation in the White Rose Health Innovation Partnership is an opportunity for industry and government in our region to use major academic research strengths both here and in the UK to:

• shift the culture from “supply-push” to “demand-pull” - with technology genuinely being translated to meet identified clinical needs

• unify three separate operating “silos” - clinical, industrial and academic- into a coherent innovation supply chain.

RETURN TO PRIOR PAGE